{"entity":{"type":"insider","cik":"0001581996","url":"/insider/0001581996","json_url":"/insider/0001581996.json","name":"Michael & Jane Hoffman 2013 Descendants","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":12,"n_filings":6,"first":"2013-08-01","last":"2014-02-24","span_basis":"filed_date"},"name_variants":[{"name":"Michael & Jane Hoffman 2013 Descendants","source":"filing","n_filings":6,"first_seen":"2013-08-01","last_seen":"2014-02-24"}],"transactions":[{"id":6579127,"accession":"0001179110-14-003410","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-003410","line_url":"/filing/0001179110-14-003410#line-2","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001581996","owner_name":"Michael & Jane Hoffman 2013 Descendants","owner_url":"/insider/0001581996","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71740.0,"shares_display":"71,740","price_per_share":8.91,"price_display":"8.91","price_state":"stated","total_value":639203.4,"total_display":"639,203.40","shares_owned_after":4518275.0,"shares_owned_after_display":"4,518,275","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-21","filed_date":"2014-02-24","scope":"insider"},{"id":6579124,"accession":"0001179110-14-003410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-003410","line_url":"/filing/0001179110-14-003410#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001581996","owner_name":"Michael & Jane Hoffman 2013 Descendants","owner_url":"/insider/0001581996","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":71740.0,"shares_display":"71,740","price_per_share":8.03,"price_display":"8.03","price_state":"stated","total_value":576072.2,"total_display":"576,072.20","shares_owned_after":4446535.0,"shares_owned_after_display":"4,446,535","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-02-20","filed_date":"2014-02-24","scope":"insider"},{"id":6807104,"accession":"0001179110-14-001425","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-14-001425","line_url":"/filing/0001179110-14-001425#line-2","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001581996","owner_name":"Michael & Jane Hoffman 2013 Descendants","owner_url":"/insider/0001581996","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25589.0,"shares_display":"25,589","price_per_share":11.86,"price_display":"11.86","price_state":"stated","total_value":303485.54,"total_display":"303,485.54","shares_owned_after":4374795.0,"shares_owned_after_display":"4,374,795","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-27","filed_date":"2014-01-27","scope":"insider"},{"id":6807099,"accession":"0001179110-14-001425","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-14-001425","line_url":"/filing/0001179110-14-001425#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001581996","owner_name":"Michael & Jane Hoffman 2013 Descendants","owner_url":"/insider/0001581996","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":31706.0,"shares_display":"31,706","price_per_share":11.96,"price_display":"11.96","price_state":"stated","total_value":379203.76,"total_display":"379,203.76","shares_owned_after":4349206.0,"shares_owned_after_display":"4,349,206","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-01-24","filed_date":"2014-01-27","scope":"insider"},{"id":4470557,"accession":"0001179110-13-017005","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-017005","line_url":"/filing/0001179110-13-017005#line-2","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001581996","owner_name":"Michael & Jane Hoffman 2013 Descendants","owner_url":"/insider/0001581996","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":4900.0,"shares_display":"4,900","price_per_share":14.39,"price_display":"14.39","price_state":"stated","total_value":70511.0,"total_display":"70,511.00","shares_owned_after":4317500.0,"shares_owned_after_display":"4,317,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-22","filed_date":"2013-11-25","scope":"insider"},{"id":4470553,"accession":"0001179110-13-017005","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-017005","line_url":"/filing/0001179110-13-017005#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001581996","owner_name":"Michael & Jane Hoffman 2013 Descendants","owner_url":"/insider/0001581996","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":100.0,"shares_display":"100","price_per_share":14.37,"price_display":"14.37","price_state":"stated","total_value":1437.0,"total_display":"1,437.00","shares_owned_after":4312600.0,"shares_owned_after_display":"4,312,600","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-22","filed_date":"2013-11-25","scope":"insider"},{"id":5353688,"accession":"0001179110-13-016805","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-016805","line_url":"/filing/0001179110-13-016805#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001581996","owner_name":"Michael & Jane Hoffman 2013 Descendants","owner_url":"/insider/0001581996","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":11.87,"price_display":"11.87","price_state":"stated","total_value":59350.0,"total_display":"59,350.00","shares_owned_after":4312500.0,"shares_owned_after_display":"4,312,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-18","filed_date":"2013-11-20","scope":"insider"},{"id":5162453,"accession":"0001179110-13-016722","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001179110-13-016722","line_url":"/filing/0001179110-13-016722#line-4","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001581996","owner_name":"Michael & Jane Hoffman 2013 Descendants","owner_url":"/insider/0001581996","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7800.0,"shares_display":"7,800","price_per_share":11.97,"price_display":"11.97","price_state":"stated","total_value":93366.0,"total_display":"93,366.00","shares_owned_after":4307500.0,"shares_owned_after_display":"4,307,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-18","scope":"insider"},{"id":5162448,"accession":"0001179110-13-016722","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001179110-13-016722","line_url":"/filing/0001179110-13-016722#line-3","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001581996","owner_name":"Michael & Jane Hoffman 2013 Descendants","owner_url":"/insider/0001581996","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":11.99,"price_display":"11.99","price_state":"stated","total_value":59950.0,"total_display":"59,950.00","shares_owned_after":4297800.0,"shares_owned_after_display":"4,297,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-18","scope":"insider"},{"id":5162443,"accession":"0001179110-13-016722","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001179110-13-016722","line_url":"/filing/0001179110-13-016722#line-2","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001581996","owner_name":"Michael & Jane Hoffman 2013 Descendants","owner_url":"/insider/0001581996","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":11.95,"price_display":"11.95","price_state":"stated","total_value":59750.0,"total_display":"59,750.00","shares_owned_after":4292800.0,"shares_owned_after_display":"4,292,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-18","scope":"insider"},{"id":5162436,"accession":"0001179110-13-016722","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001179110-13-016722","line_url":"/filing/0001179110-13-016722#line-1","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001581996","owner_name":"Michael & Jane Hoffman 2013 Descendants","owner_url":"/insider/0001581996","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1900.0,"shares_display":"1,900","price_per_share":12.21,"price_display":"12.21","price_state":"stated","total_value":23199.0,"total_display":"23,199.00","shares_owned_after":4299700.0,"shares_owned_after_display":"4,299,700","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-15","filed_date":"2013-11-18","scope":"insider"},{"id":4972364,"accession":"0001179110-13-012441","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0001179110-13-012441","line_url":"/filing/0001179110-13-012441#line-9","is_derivative":false,"issuer_cik":"0001130598","issuer_name":"Onconova Therapeutics, Inc.","issuer_ticker":"ONTX","issuer_name_source":null,"issuer_url":"/issuer/0001130598","owner_cik":"0001581996","owner_name":"Michael & Jane Hoffman 2013 Descendants","owner_url":"/insider/0001581996","role":"Ten percent owner","officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000000.0,"shares_display":"1,000,000","price_per_share":15.0,"price_display":"15.00","price_state":"stated","total_value":15000000.0,"total_display":"15,000,000.00","shares_owned_after":4287800.0,"shares_owned_after_display":"4,287,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-07-30","filed_date":"2013-08-01","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":12,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":12,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":12},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001130598","name":"Onconova Therapeutics, Inc.","url":"/issuer/0001130598","role":"Ten percent owner","n_filings":6,"first_seen":"2013-08-01","last_seen":"2014-02-24"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001581996","retrieved_at":"2026-08-21T20:18:07+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}